FindTrial
Sign In

Study to assess the efficacy of deep breathing Pranayama technique in addition to conventional allopathic treatment in management of COVID19

â??Introduction of deep breathing Pranayama technique as â??add-onâ?? in management of confirmed cases with COVID 19: A Prospective Study with Retrospective Controlâ??â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028362
Enrollment
278
Registered
2020-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

Intervention1: Deep breathing Pranayama breathing technique(A type of chest physiotherapy), Conventional allopathic treatment: One cycle of Deep breathing Pranayama technique (a type of chest physioth

Sponsors

Dr Anuja Santosh Kulkarni
Lead Sponsor
Jagjivan Ram Railway Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients confirmed cases of COVID 19 admitted to our hospital All adult patients Aged 18 years and above upto 99 yrs, irrespective of gender and co morbidities will be included in the study

Exclusion criteria

Exclusion criteria: 1)Unconscious patients 2)Mentally challenged patients 3)Pregnant Women 4)Children below age of 18 years 5)Non compliant to add on technique 6)Those requiring mechanical ventilator with room air oxygen saturation spo2 will be excluded from study

Design outcomes

Primary

MeasureTime frame
1)Length of time to clinical improvement Normalisation of respiratory rate, oxygen saturation, alleviation of cough 2)Number of participants with normal oxygen saturation on day 11 15 and 21 3)Length of time of normalisation of oxygen saturation (Time frame upto 28 days) 4)Duration of Supplemental Oxygen Time frame :Upto 28 daysTimepoint: Outcomes will be assessed at baseline,Day 3, Day 5, 1week(7days) ,2weeks(14 Days), 3weeks(21days) and at 4weeks(28days)—

Secondary

MeasureTime frame
1)Reduction in Anxiety score on HAM A scale 2)percentage of mortality before and afterTimepoint: 1)Time frame Anxiety score at day 0,1,3,5,7,14,21,28 2)Percentage of mortality Time frame : 28 days—

Countries

India

Contacts

Public ContactDr Anuja Santosh Kulkarni

Jagjivan Ram railway Hospital

dr.anujakulkarni@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026